Reuters logo
BRIEF-Cytosorbents posts safety data from Refresh I cardiac surgery trial
2016年10月5日 / 上午11点17分 / 1 年前

BRIEF-Cytosorbents posts safety data from Refresh I cardiac surgery trial

Oct 5 (Reuters) - Cytosorbents Corp:

* Announces positive top line safety data from refresh I cardiac surgery trial

* DSMB found no safety concerns related to Cytosorb device, achieving primary safety endpoint Source text for Eikon: Further company coverage:

我们的标准汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below